Morning Wrap

Today ’s Newsflow Equity Research 21 Sep 2015 Upcoming Events Select headline to navigate to article

Playtech acquisition sees short term delay Company Events 23-Sep Origin Enterprises; Q4 2015 Results 28-Sep ARYZTA; Q4 2015 Results

UDG Healthcare Disposal of the Distribution business to provide firepower for next leg of growth

Economic View Political risks reduced after clear Greek election results

FBD Holdings Zurich and RSA merger talks terminated

Economic Events Ireland

United Kingdom 24-Sep BBA Loans for House Purchase

United States 23-Sep US Manufacturing PMI 24-Sep Durable Goods Orders New Home Sales 25-Sep GDP Annualized QoQ Core PCE QoQ US Composite PMI U. of Michigan Sentiment

Europe 23-Sep Eurozone Manufacturing PMI Eurozone Services PMI

Goodbody Capital Markets Equity Research +353 1 6419221 Equity Sales +353 1 6670222 Bloomberg GDSE

Goodbody Stockbrokers (trading as Goodbody) is regulated by the Central Bank of Ireland. For the attention of US clients of Goodbody Securities Inc, this third-party research report has been produced by our affiliate Goodbody Stockbrokers. Please see the end of this report for analyst certifications and other important disclosures. Goodbody Morning Wrap

Playtech Plus500 acquisition sees short term delay

Playtech announced on Friday evening that the receipt of all regulatory approvals in relation Recommendation: Buy to its acquisition of Plus500 is taking longer than originally anticipated. This has come as a Closing Price: £8.58 result of the high profile nature of the Plus500 acquisition. The group now expects the acquisition to be completed by the end of November 2015, but remains hopeful of an Gavin Kelleher +353-1-641 0423 October completion (it notes this is still within the relevant regulatory and statutory [email protected] timetables). Playtech states that its board is not aware of any issues which would give rise to the required regulatory approvals not being granted in due course. It has already received approval from the Cyprus Securities and Exchange Commission. In terms of the group’s acquisition of Ava Trade, the group expects this to complete around the end of September 2015, broadly in line with its prior expectation.

The news that the Plus500 deal is seeing some regulatory delays could cause some concern. However, Playtech appears confident the deal will still go through in Q4. The deal has already received Cypriot regulatory approval so the delay would appear to be related to the FCA approval in the UK. Our forecasts include the acquisition of Plus500 from October 1st 2015 onwards so there is risk of this slipping slightly.

Home…

Page 2 21 Sep. 15 Goodbody Morning Wrap

UDG Healthcare Disposal of the Distribution business to provide firepower for next leg of growth

On Friday UDG Healthcare announced the disposal of its Distribution business to McKesson Recommendation: Buy for a gross consideration of €407.5m which represents a 13.4x EV/EBITA multiple (€30m of Closing Price: £5.41 EBITA disposed, representing c.25% of group profits). As part of the transaction UDG will David O'Brien dispose of the Irish United Drug business, the Sangers business in Northern Ireland and the +353-1-641 9230 Masta business in the UK. This follows the disposal of the UniDrug business last year and is david.a.o'[email protected] very much in line with management’s outlined strategy. The Aquilant business, while part of the Supply Chain Service division, will remain with UDG.

The disposal allows UDG to focus on the higher growth businesses of Ashfield (growing at 9% in H115) and Sharp Packaging (growing 30% in H115). Indeed, the net proceeds of the deal will see UDG’s forecast leverage move from 1.8x EBITDA to a net cash position of c.€100m. With no mention of cash returns, it is clear management will be using the capital to grow the core Ashfield and Packaging businesses further through acquisition / capex. The margin and returns profile of the Group will significantly improve with the former increasing from 5% to 11%.

Following 15 years as CEO Liam Fitzgerald is retiring from UDG with current COO Brendan McAtamney taking over. Mr FitzGerald has overseen a period of immense transformation in UDG from a 100% Irish focused business to an almost 100% international business that is underpinned by attractive structural growth pillars.

In our view this appears to be a very attractive deal for UDG, which alongside the clear financial benefits, will allow management to focus 100% on the core growth businesses going forward. The strong financial position will provide firepower to fund the next leg of growth for UDG. We reiterate our BUY recommendation.

Home…

Page 3 21 Sep. 15 Goodbody Morning Wrap

Economic View Political risks reduced after clear Greek election results

European policymakers will be breathing a sigh of relief this morning following the results of Dermot O’Leary +353-1-641 9167 the latest Greek general election. Alexis Tsipras’ decision to call a snap election looks to have [email protected] paid off, with his Syriza party winning 35.5% of the votes, with the nearest challenger – New Democracy – on 28.1%. Adding on the bonus seats for being the largest party, this translates into 145 seats. A coalition with the centre-right Independent Greeks (10 seats) was announced last night. While a parliamentary majority of five is small, Tsipras has managed to rid his party of the more hardliner, anti-bailout faction of his party. Those dissidents failed to reach the 3% threshold required for making it into the Greek parliament.

The vote gives Tsipras an important mandate to continue with the programme agreed with European creditors back in July, the decision that ultimately triggered these fresh set of elections. The first job of the new government will be to vote through prior actions for the latest tranche of the bailout funds.

Markets should also welcome this latest result in Greece. Greece was exceptionally close to leaving/getting kicked out of the single currency just two months ago. Now it appears that the spectre of Greek political concerns may fade as an issue for markets. Politics, though, will certainly not fade as an issue, with the Portuguese, Spanish and Irish general elections all due to take place over the coming months.

Home…

FBD Holdings Zurich and RSA merger talks terminated

Zurich and RSA have provided trading updates this morning and also announced that they Recommendation: Restricted are not proceeding with their proposed merger. Zurich has indicated that it is expected to Closing Price: €7.05 incur losses from the Tianjin port explosion plus it also expects weaker than anticipated Eamonn Hughes trading in its General Insurance business to continue into Q3. In light of the recent +353-1-641 9442 deterioration in trading performance, it is terminating discussions with RSA, which itself flags [email protected] that trading for July and August has been ahead of expectations.

The proposed merger of Zurich and RSA would have brought together the 6th largest insurer in Ireland (Zurich) with the joint largest (RSA), creating a clear market leader, with market share in the high-20s. Failure to consummate a marriage now leaves them to their own devices and plays down the M&A angle in Ireland for the time being. If either of them are to get involved in M&A in the future, it is more than likely going to be RSA, particularly since it looks like Zurich first has a few things to sort out in its own business.

Home…

Page 4 21 Sep. 15 Goodbody Morning Wrap

Market Data Top 10 Covered Companies

Company Price Mkt Cap Absolute Relative to European Sector P/E (LC) (LCM) 1 Day 1 Week 1 Mth Ytd 1 Day 1 Week 1 Mth Ytd 2015f 2016f AIB Group 0.08 40,833 - 2.6 -9.4 -1.3 1.8 2.9 -0.9 -4.7 25.3 28.4 CRH 25.75 21,003 -1.6 -1.4 -7.6 29.4 0.1 -1.1 1.1 24.9 23.0 14.1 Ryanair 13.55 18,759 0.3 -0.5 5.2 38.2 2.2 -0.2 15.1 33.4 13.1 15.1 IAG 6.01 12,207 -0.6 2.9 9.2 23.5 1.2 3.2 19.4 19.3 11.6 8.2 Wolseley 41.36 10,756 -1.8 -1.5 -4.5 12.2 -0.1 -0.8 0.9 15.2 17.2 15.7 Kerry Group 65.79 11,566 -1.0 3.1 -5.4 15.3 0.8 3.4 3.5 11.3 22.0 20.1 Bank of Ireland 0.34 11,108 -2.0 -2.0 -5.5 9.6 -0.2 -1.7 3.4 5.8 10.8 11.2 easyJet 17.43 6,867 -0.7 -1.0 -0.1 4.3 0.9 -0.3 5.6 7.1 12.5 11.8 Mondi 13.80 6,701 -2.0 -5.9 -11.4 31.4 -0.2 -5.7 -3.0 26.9 14.4 13.7 20.31 5,017 -0.8 0.1 -3.4 9.4 0.9 0.8 2.1 12.3 16.1 13.7

Indices ISEQ performance

% Price 1 Day 1 Week 1 Mth Ytd 7,000 ISEQ 6,467.17 -0.79 0.30 -1.83 23.78 6,500 FTSE 100 6,104.11 -1.34 -0.22 -6.47 -7.04 6,000 DAX 30 9,916.16 -3.06 -2.05 -9.16 1.13 CAC 40 4,535.85 -2.56 -0.28 -8.76 6.16 5,500

FTSE Eurofirst 300 1,397.57 -1.90 -0.25 -8.98 2.12 5,000 Nasdaq 4,827.23 -1.36 0.10 -4.59 1.93 4,500 S&P 500 1,958.03 -1.62 -0.15 -6.62 -4.90 Dow Jones 16,384.58 -1.74 -0.30 -6.43 -8.07 4,000 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 Nikkei 225 18,070.21 -1.96 -1.06 -12.09 3.55

Exchange Rates

Current Px 1 day Px 1 Week Px Dec14 Avg Ytd

Stg/€ 0.730 0.729 0.733 0.776 0.728 STOXX 600 performance US$/€ 1.138 1.132 1.129 1.210 1.115 CHF/€ 1.093 1.097 1.101 1.202 1.062 420

JPY/€ 136.473 136.822 136.116 145.079 134.819 400

Bonds 380

Yield 1 Day Yld 1 Wk Yld 1 Mth Yld 3 Mth 360

US 2 Yr 0.68 0.00 0.68 -0.04 0.04 340 US 10 Yr 2.13 -0.05 -0.06 -0.06 -0.20 320

UK 2 Yr 0.60 -0.09 0.01 -0.14 -0.11 300 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15 UK 10 Yr 1.72 -0.12 0.01 -0.17 -0.33

BD 2 Yr -0.25 -0.04 0.01 -0.25 -0.05

BD 10 Yr 0.66 -0.12 0.01 0.66 -0.14

Irish 10 Yr 1.25 -0.12 -0.01 0.01 -0.40

Commodities FTSE 250 performance

% Current 1 day 5 day 1 Mth 1 Yr 18,500

Brent (ICE $/bbl) 47.47 -3.28 -1.39 -2.75 -51.41 18,000

Gasoline (NYM $/Gal) 1.36 -1.44 -1.00 -17.65 -47.04 17,500 Heat Oil (NYM $/Gal) 1.49 -2.55 -3.83 -4.36 -45.04 17,000 Nat.Gas 2.61 -1.77 -3.27 -3.66 -33.38 16,500 16,000 Gold $/oz 1,141.50 2.15 3.65 2.70 -6.47 15,500 Silver $/ozt 15.26 3.39 4.66 0.20 -17.51 15,000

Copper U$/MT 5,358.00 -0.20 0.11 7.15 -22.57 14,500

Wheat $/BU 4.87 1.09 0.36 -2.41 -0.36 14,000 Sep-14 Dec-14 Mar-15 Jun-15 Sep-15

Source : FactSet

Page 5 21 Sep. 15 Goodbody Morning Wrap

Issuer & Analyst Disclosures

Analyst Certification The named Research Analyst certifies that: (1) All of the views expressed in this research report accurately reflect my personal views about any and all of the subject securities and issuers. (2) No part of my remuneration was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by me in this report.

Regulatory Information Goodbody Stockbrokers, trading as Goodbody, is regulated by the Central Bank of Ireland. Goodbody is a member of the Irish Stock Exchange and the London Stock Exchange. Goodbody is a member of the FEXCO group of companies. This publication has been approved by Goodbody Stockbrokers. The information has been taken from sources we believe to be reliable, we do not guarantee their accuracy or completeness and any such information may be incomplete or condensed. All opinions and estimates constitute best judgement at the time of publication and are subject to change without notice. The information, tools and material presented in this document are provided to you for information purposes only and are not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities.

Conflicts of Interest Goodbody Stockbrokers has procedures and policies in place to identify and manage any potential conflicts of interest that arise in connection with its research business. Goodbody Stockbrokers’ analysts and other staff who are involved in the preparation and dissemination of research operate and have a management reporting line that is independent to its Corporate Finance business. Information barriers are in place between the Corporate Finance arm and the Research arm to ensure that any confidential and or price sensitive information is handled in an appropriate manner.

Our Investment Research Conflicts of Interest Policy is available at Conflicts of Interest

Investors should be aware, that, where appropriate, research may be disclosed to the issuer(s) in advance of publication in order to correct factual inaccuracies only and not to materially amend the research in any way. Goodbody Stockbrokers is satisfied that it has operational procedures in place, which ensure that such disclosures will not compromise the report’s objectivity.

Goodbody was the co-lead manager in an offering of securities in Permanent TSB Group Holdings Plc in the last 12 months. Goodbody was the co-lead manager for Hibernia REIT Plc for a public fund raising in the past 12 months. Goodbody is acting as a financial advisor to CRH on the proposed acquisition of certain assets being disposed by Lafarge and Holcim. International Consolidated Airlines Group has been an investment banking client of Goodbody’s in the past 12 months. Goodbody Stockbrokers acts as corporate broker to AIB Group, Applegreen, Datalex, FBD Holdings, First Derivatives, , , Hibernia REIT, ICG, Kingspan, Origin Enterprises, , UDG Healthcare, and UTV Media A complete list of the companies that Goodbody Stockbrokers makes a market in is available at Regulatory Disclosures

Page 6 21 Sep. 15 Goodbody Morning Wrap

Other disclosures

A description of this company is available at Company Descriptions

All prices used in this report are as at close of business of the previous working day unless otherwise indicated.

A summary of our standard valuation methods are available at Valuation Methodologies

A summary of share price recommendations and whether material investment banking services have been provided to these companies is available at Regulatory Disclosures

Other important disclosures are available at Regulatory Disclosures

Goodbody Stockbrokers updates its recommendations on a regular basis. A breakdown of all recommendations provided by Goodbody Stockbrokers is available at Regulatory Disclosures Where Goodbody Stockbrokers has provided investment banking services to an issuer, details of the proportion of buys, holds and sells attributed to that issuer will also be included. This is updated on a quarterly basis.

The date on which stock recommendations were first released for all stocks mentioned in this report are available at http://www.goodbody.ie/research_disclosures/regulatorydisclosures/index.html. If a different recommendation has been made in the previous twelve months, this will also be disclosed here.

Recommendation Definitions Goodbody Stockbrokers uses the terms “Buy”, “Sell” and “Hold. The term “Buy” means that the analyst expects the security to appreciate in excess of 10% over a twelve month period. The term “Sell” means that the security is expected to decline in excess of 10% over the next twelve months. The term “Hold” means that the analyst expects the security to neither appreciate more than 10%, or depreciate more than 10% over the next twelve months.

On 26th November, 2012, the terms “Add” and “Reduce” were removed from the Recommendation Definitions and both were replaced with the “Hold” recommendation. Any Previous Recommendation that refers to either an “Add” means that the analyst expected the security to appreciate by up to 15% over a twelve month period. Any Previous Recommendation to “Reduce” means that the analyst expected the security to decline by up to 15% over the next twelve months.

In the event that a stock is delisted the firm will automatically cease coverage. If however the firm ceases to cover a stock for any other reason the firm will disclose this fact.

Distribution of research to clients of Goodbody Securities Inc (GSI) in the US

GSI distributes third-party research produced by its affiliate, Goodbody Stockbrokers GSI is a member of FINRA and SIPC GSI does not act as a market-maker.

This information was current as of the last business day of the month preceding the date of the report. An affiliate of GSI may have acted, in the past 12 months, as lead manager/co-lead manager of a publicly disclosed offer of the securities in this company. Investors should be aware that an affiliate of GSI may have provided investment banking or non-investment-banking services to, and received compensation from this company in the past 12 months or may provide such services in the next three months. The term investment banking services includes acting as broker as well as the provision of corporate finance services, such as underwriting and managing or advising on a public offer. All transactions by US persons involving securities of companies discussed in this report are to be effected through GSI.

Disclaimer While all reasonable care has been taken in the production and dissemination of this report it is not to be relied upon in substitution for the exercise of independent judgement. Nothing in this report constitutes investment, legal, accounting or tax advice, or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, or otherwise constitutes a personal recommendation to you.

Private customers having access, should not act upon it in anyway but should consult with their independent professional advisors. The price, value and income of certain investments may rise or may be subject to sudden and large falls in value. You may not recover the total amount originally invested. Past performance should not be taken as an indication or guarantee of future performance; neither should simulated performance. The value of securities may be subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities.

All material presented in this report, unless specifically indicated otherwise is copyright to Goodbody Stockbrokers. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Goodbody Stockbrokers.

Goodbody, Ballsbridge Park, Ballsbridge, Dublin 4, Ireland T (+353 1) 6670400 W www.goodbody.ie E [email protected] Page 7 21 Sep. 15